Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1768657019 | Naloxone hydrochloride + pentazocine hydrochloride (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 1779959012 | Naloxone hydrochloride + pentazocine hydrochloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3490665017 | Product containing naloxone hydrochloride and pentazocine hydrochloride (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494859010 | Product containing naloxone hydrochloride and pentazocine hydrochloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Is a | Product containing naloxone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Is a | Product containing pentazocine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has active ingredient | Chelating agent | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has active ingredient | Naloxone hydrochloride | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has active ingredient | Pentazocine hydrochloride | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has active ingredient | Pentazocine (substance) | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has active ingredient | Opiate agonist-antagonist | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Is a | Product containing pentazocine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Is a | Naloxone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing naloxone hydrochloride and pentazocine hydrochloride | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing naloxone hydrochloride and pentazocine hydrochloride | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR